Cargando…

Widespread Disruptions of White Matter in Familial Multiple Sclerosis: DTI and NODDI Study

Diffusion tensor imaging (DTI) is a noninvasive, quantitative MRI technique that measures white matter (WM) integrity. Many brain dimensions are heritable, including white matter integrity measured with DTI. Family studies are valuable to provide insights into the interactive effects of non-environm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gharaylou, Zeinab, Sahraian, Mohammad Ali, Hadjighassem, Mahmoudreza, Kohanpour, Mohsen, Doosti, Rozita, Nahardani, Shima, Moghadasi, Abdorreza Naser
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415561/ https://www.ncbi.nlm.nih.gov/pubmed/34484098 http://dx.doi.org/10.3389/fneur.2021.678245

Ejemplares similares

Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional survey
por: Fattahi, Mohammad Reza, et al.
Publicado: (2022)

Assessing Microstructural Substrates of White Matter Abnormalities: A Comparative Study Using DTI and NODDI
por: Timmers, Inge, et al.
Publicado: (2016)

Analgesic Effect of Bumetanide on Neuropathic Pain in Patients With Spinal Cord Injury
por: Nasirinezhad, Farinaz, et al.
Publicado: (2021)

NODDI-DTI: Estimating Neurite Orientation and Dispersion Parameters from a Diffusion Tensor in Healthy White Matter
por: Edwards, Luke J., et al.
Publicado: (2017)

White Matter Abnormalities and Cognitive Deficit After Mild Traumatic Brain Injury: Comparing DTI, DKI, and NODDI
por: Huang, Sihong, et al.
Publicado: (2022)

Is anemia a probable cause of fatigue in patients with multiple sclerosis?
por: Mir-Reza, Soha, et al.
Publicado: (2013)

The evolution of white matter microstructural changes after mild traumatic brain injury: A longitudinal DTI and NODDI study
por: Palacios, E. M., et al.
Publicado: (2020)

A randomized controlled trial investigating the effects of a mediterranean-like diet in patients with multiple sclerosis-associated cognitive impairments and fatigue
por: Razeghi-Jahromi, Soodeh, et al.
Publicado: (2020)

Long-term administration of bumetanide improve functional recovery after spinal cord injury in rats
por: Hashemizadeh, Shiva, et al.
Publicado: (2022)

Longitudinal Effects of Bumetanide on Neuro-Cognitive Functioning in Drug-Resistant Epilepsy
por: Gharaylou, Zeinab, et al.
Publicado: (2019)

Economic sanctions against Iran as an important factor in threatening the health of patients with multiple sclerosis
por: Sahraian, Mohammad Ali, et al.
Publicado: (2021)

Beta-thalassemia intermedia with ischemic transients misdiagnosed as multiple sclerosis: A case report
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

C-NODDI: a constrained NODDI model for axonal density and orientation determinations in cerebral white matter
por: Alsameen, Maryam H., et al.
Publicado: (2023)

Multiple sclerosis and human leukocyte antigen genotypes: Focus on the Middle East and North Africa region
por: Maghbooli, Zhila, et al.
Publicado: (2020)

Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms
por: Rezaeimanesh, Nasim, et al.
Publicado: (2020)

Implementing coronavirus disease 2019 scale-up registry protocol in national multiple sclerosis registry system of Iran
por: Eskandarieh, Sharareh, et al.
Publicado: (2021)

Evaluation of the risk of cervical cancer in patients with Multiple Sclerosis treated with cytotoxic agents: A cohort study
por: Doosti, Rozita, et al.
Publicado: (2018)

Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients
por: Haji Akhoundi, Fahimeh, et al.
Publicado: (2020)

The first presentation of COVID-19 two hours after vaccination in a patient with multiple sclerosis: Can COVID vaccine provoke cytokine storm in a patient with asymptomatic COVID-19?
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

The study of COVID-19 infection following vaccination in patients with multiple sclerosis
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Attitudes toward vaccination in patients with multiple sclerosis: A report from Iran
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

The perspective of Iranian patients with multiple sclerosis on the third dose of COVID-19 vaccine
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Association Between Proteomic Blood Biomarkers and DTI/NODDI Metrics in Adolescent Football Players: A Pilot Study
por: Kawata, Keisuke, et al.
Publicado: (2020)

The Possible Direct Correlation between Cognitive Impairment and Fear of Catching COVID-19 among Patients with Multiple Sclerosis
por: Saeedi, Roghayyeh, et al.
Publicado: (2021)

Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV
por: Ali Sahraian, Mohammad, et al.
Publicado: (2021)

Depression, anxiety, and fear of COVID-19 in patients with multiple sclerosis in pandemic era: a cross-sectional study
por: Alirezaei, Mohammad, et al.
Publicado: (2021)

A focus on allogeneic mesenchymal stromal cells as a versatile therapeutic tool for treating multiple sclerosis
por: Shokati, Ameneh, et al.
Publicado: (2021)

Epidemiology of multiple sclerosis in Qom: Demographic study in Iran
por: Rezaali, Saeed, et al.
Publicado: (2013)

Telemedicine as a strategic intervention for cognitive rehabilitation in MS patients during COVID-19
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review
por: Ghadiri, Fereshteh, et al.
Publicado: (2023)

Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis
por: Sahraian, Mohammad Ali, et al.
Publicado: (2020)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): A systematic review and meta-analysis
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2021)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2021)

Is Body Mass Index (BMI) Associated with Risk and Outcomes of COVID-19 in Iranian Multiple Sclerosis Patients?
por: Rezaeimanesh, Nasim, et al.
Publicado: (2023)

Predictors of suicidal ideation among Iranian patients with multiple sclerosis
por: Asgarian, Fatemeh Sadat, et al.
Publicado: (2020)

Neuroplasticity in Early Onset Multiple Sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2014)

Multiple Sclerosis in Parsis: A Historical Issue
por: NASER MOGHADASI, Abdorreza
Publicado: (2014)

Medical history risk factors in primary progressive multiple sclerosis: A case-control study
por: Maroufi, Hossein, et al.
Publicado: (2021)

Knowledge regarding COVID-19 pandemic in patients with multiple sclerosis (MS): A report from Iran
por: Sahraian, Mohammad Ali, et al.
Publicado: (2020)

Whole grains and legumes consumption in association with neuromyelitis optica spectrum disorder odds
por: Rezaeimanesh, Nasim, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_drdkll8912j0rqjsrsu6ao68rj